Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis

BackgroundWhile recent studies have separately explored mutational signatures and the tumor microenvironment (TME), there is limited research on the associations of both factors in a pan-cancer context.Materials and methodsWe performed a pan-cancer analysis of over 8,000 tumor samples from The Cance...

Full description

Bibliographic Details
Main Authors: Li-Zhi Luo, Sheng Li, Chen Wei, Jiao Ma, Li-Mei Qian, Yan-Xing Chen, Shi-Xiang Wang, Qi Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1186357/full
_version_ 1797822559819923456
author Li-Zhi Luo
Sheng Li
Chen Wei
Jiao Ma
Li-Mei Qian
Yan-Xing Chen
Shi-Xiang Wang
Qi Zhao
author_facet Li-Zhi Luo
Sheng Li
Chen Wei
Jiao Ma
Li-Mei Qian
Yan-Xing Chen
Shi-Xiang Wang
Qi Zhao
author_sort Li-Zhi Luo
collection DOAJ
description BackgroundWhile recent studies have separately explored mutational signatures and the tumor microenvironment (TME), there is limited research on the associations of both factors in a pan-cancer context.Materials and methodsWe performed a pan-cancer analysis of over 8,000 tumor samples from The Cancer Genome Atlas (TCGA) project. Machine learning methods were employed to systematically explore the relationship between mutational signatures and TME and develop a risk score based on TME-associated mutational signatures to predict patient survival outcomes. We also constructed an interaction model to explore how mutational signatures and TME interact and influence cancer prognosis.ResultsOur analysis revealed a varied association between mutational signatures and TME, with the Clock-like signature showing the most widespread influence. Risk scores based on mutational signatures mainly induced by Clock-like and AID/APOBEC activity exhibited strong pan-cancer survival stratification ability. We also propose a novel approach to predict transcriptome decomposed infiltration levels using genome-derived mutational signatures as an alternative approach for exploring TME cell types when transcriptome data are unavailable. Our comprehensive analysis revealed that certain mutational signatures and their interaction with immune cells significantly impact clinical outcomes in particular cancer types. For instance, T cell infiltration levels only served as a prognostic biomarker in melanoma patients with high ultraviolet radiation exposure, breast cancer patients with high homologous recombination deficiency signature, and lung adenocarcinoma patients with high tobacco-associated mutational signature.ConclusionOur study comprehensively explains the complex interplay between mutational signatures and immune infiltration in cancer. The results highlight the importance of considering both mutational signatures and immune phenotypes in cancer research and their significant implications for developing personalized cancer treatments and more effective immunotherapy.
first_indexed 2024-03-13T10:10:53Z
format Article
id doaj.art-c77c1e6d042a44c8b4878fd7153bef55
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-13T10:10:53Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-c77c1e6d042a44c8b4878fd7153bef552023-05-22T04:26:00ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-05-011410.3389/fimmu.2023.11863571186357Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysisLi-Zhi Luo0Sheng Li1Chen Wei2Jiao Ma3Li-Mei Qian4Yan-Xing Chen5Shi-Xiang Wang6Qi Zhao7State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Sun Yat-Sen University, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Sun Yat-Sen University, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Sun Yat-Sen University, Guangzhou, ChinaSchool of Public Health, Sun Yat-Sen University, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Sun Yat-Sen University, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Sun Yat-Sen University, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Sun Yat-Sen University, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Sun Yat-Sen University, Guangzhou, ChinaBackgroundWhile recent studies have separately explored mutational signatures and the tumor microenvironment (TME), there is limited research on the associations of both factors in a pan-cancer context.Materials and methodsWe performed a pan-cancer analysis of over 8,000 tumor samples from The Cancer Genome Atlas (TCGA) project. Machine learning methods were employed to systematically explore the relationship between mutational signatures and TME and develop a risk score based on TME-associated mutational signatures to predict patient survival outcomes. We also constructed an interaction model to explore how mutational signatures and TME interact and influence cancer prognosis.ResultsOur analysis revealed a varied association between mutational signatures and TME, with the Clock-like signature showing the most widespread influence. Risk scores based on mutational signatures mainly induced by Clock-like and AID/APOBEC activity exhibited strong pan-cancer survival stratification ability. We also propose a novel approach to predict transcriptome decomposed infiltration levels using genome-derived mutational signatures as an alternative approach for exploring TME cell types when transcriptome data are unavailable. Our comprehensive analysis revealed that certain mutational signatures and their interaction with immune cells significantly impact clinical outcomes in particular cancer types. For instance, T cell infiltration levels only served as a prognostic biomarker in melanoma patients with high ultraviolet radiation exposure, breast cancer patients with high homologous recombination deficiency signature, and lung adenocarcinoma patients with high tobacco-associated mutational signature.ConclusionOur study comprehensively explains the complex interplay between mutational signatures and immune infiltration in cancer. The results highlight the importance of considering both mutational signatures and immune phenotypes in cancer research and their significant implications for developing personalized cancer treatments and more effective immunotherapy.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1186357/fullmutational signaturestumor microenvironmentcancer genomicscancer prognosisimmunotherapy
spellingShingle Li-Zhi Luo
Sheng Li
Chen Wei
Jiao Ma
Li-Mei Qian
Yan-Xing Chen
Shi-Xiang Wang
Qi Zhao
Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis
Frontiers in Immunology
mutational signatures
tumor microenvironment
cancer genomics
cancer prognosis
immunotherapy
title Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis
title_full Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis
title_fullStr Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis
title_full_unstemmed Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis
title_short Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis
title_sort unveiling the interplay between mutational signatures and tumor microenvironment a pan cancer analysis
topic mutational signatures
tumor microenvironment
cancer genomics
cancer prognosis
immunotherapy
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1186357/full
work_keys_str_mv AT lizhiluo unveilingtheinterplaybetweenmutationalsignaturesandtumormicroenvironmentapancanceranalysis
AT shengli unveilingtheinterplaybetweenmutationalsignaturesandtumormicroenvironmentapancanceranalysis
AT chenwei unveilingtheinterplaybetweenmutationalsignaturesandtumormicroenvironmentapancanceranalysis
AT jiaoma unveilingtheinterplaybetweenmutationalsignaturesandtumormicroenvironmentapancanceranalysis
AT limeiqian unveilingtheinterplaybetweenmutationalsignaturesandtumormicroenvironmentapancanceranalysis
AT yanxingchen unveilingtheinterplaybetweenmutationalsignaturesandtumormicroenvironmentapancanceranalysis
AT shixiangwang unveilingtheinterplaybetweenmutationalsignaturesandtumormicroenvironmentapancanceranalysis
AT qizhao unveilingtheinterplaybetweenmutationalsignaturesandtumormicroenvironmentapancanceranalysis